CU23575A1 - Composición farmacéutica que comprende la proteína nmb0606 - Google Patents
Composición farmacéutica que comprende la proteína nmb0606Info
- Publication number
- CU23575A1 CU23575A1 CU20060075A CU20060075A CU23575A1 CU 23575 A1 CU23575 A1 CU 23575A1 CU 20060075 A CU20060075 A CU 20060075A CU 20060075 A CU20060075 A CU 20060075A CU 23575 A1 CU23575 A1 CU 23575A1
- Authority
- CU
- Cuba
- Prior art keywords
- composition
- nmb0606
- pharmaceutical composition
- composition including
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se relaciona con el campo de la medicina, particularmente con el desarrollo de una composición farmacéutica que comprende la proteína NMB0606. La composición de la presente invención confiere protección contra diferentes enfermedades, causadas o no por patógenos. La proteína NMB0606 se identificó como componente de las preparaciones de vesículas de membrana externa (VME) de Neisseria meningitidis, se obtuvo mediante la tecnología del ácido desoxirribonucleico (ADN) recombinante y se evaluó su inmunogenicidad y actividad protectora en modelos animales. Por el elevado grado de conservación del gen que codifica para la proteína NMB0606, la composición que la comprende posee alto valor como antígeno inductor de una respuesta inmune de amplia reactividad. La composición de esta invención es aplicable en la medicina humana.
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060075A CU23575A1 (es) | 2006-03-31 | 2006-03-31 | Composición farmacéutica que comprende la proteína nmb0606 |
| US12/295,198 US20100129387A1 (en) | 2006-03-31 | 2007-03-29 | Pharmaceutical composition containing the nmb0606 protein |
| AU2007234214A AU2007234214A1 (en) | 2006-03-31 | 2007-03-29 | Pharmaceutical composition containing the NMB0606 protein |
| ARP070101323A AR060797A1 (es) | 2006-03-31 | 2007-03-29 | Composicion farmaceutica que comprende la proteina nmb0606 |
| MX2008012665A MX2008012665A (es) | 2006-03-31 | 2007-03-29 | Composicion farmaceutica que comprende la proteina nmb0606. |
| KR1020087026335A KR20080108576A (ko) | 2006-03-31 | 2007-03-29 | Ｎｍｂ0606 단백질을 포함하는 약학적 조성물 |
| BRPI0709922-3A BRPI0709922A2 (pt) | 2006-03-31 | 2007-03-29 | composiÇço farmacÊutica contendo a proteÍna nmb0606 |
| PCT/CU2007/000013 WO2007112703A2 (es) | 2006-03-31 | 2007-03-29 | Composición farmacéutica que comprende la proteína nmb0606 |
| CA002647465A CA2647465A1 (en) | 2006-03-31 | 2007-03-29 | Pharmaceutical composition containing the nmb0606 protein |
| EP07721809A EP2011509A2 (en) | 2006-03-31 | 2007-03-29 | Pharmaceutical composition containing the nmb0606 protein |
| CNA2007800182864A CN101448518A (zh) | 2006-03-31 | 2007-03-29 | 含有nmb0606蛋白的药物组合物 |
| ZA200808768A ZA200808768B (en) | 2006-03-31 | 2008-10-14 | Pharmaceutical composition containing the NMB0606 protein |
| NO20084525A NO20084525L (no) | 2006-03-31 | 2008-10-28 | Farmasoytiske sammensetninger inneholdende NMB0606-protein |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060075A CU23575A1 (es) | 2006-03-31 | 2006-03-31 | Composición farmacéutica que comprende la proteína nmb0606 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23575A1 true CU23575A1 (es) | 2010-09-30 |
Family
ID=38535626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20060075A CU23575A1 (es) | 2006-03-31 | 2006-03-31 | Composición farmacéutica que comprende la proteína nmb0606 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100129387A1 (es) |
| EP (1) | EP2011509A2 (es) |
| KR (1) | KR20080108576A (es) |
| CN (1) | CN101448518A (es) |
| AR (1) | AR060797A1 (es) |
| AU (1) | AU2007234214A1 (es) |
| BR (1) | BRPI0709922A2 (es) |
| CA (1) | CA2647465A1 (es) |
| CU (1) | CU23575A1 (es) |
| MX (1) | MX2008012665A (es) |
| NO (1) | NO20084525L (es) |
| WO (1) | WO2007112703A2 (es) |
| ZA (1) | ZA200808768B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20240433T1 (hr) | 2016-09-02 | 2024-07-05 | Sanofi Pasteur, Inc. | Cjepivo protiv neisseria meningitidis |
| EP4007600A4 (en) * | 2019-08-01 | 2023-08-23 | Trustees of Tufts College | VACCINE COMPOSITIONS AND ANTIGEN SELECTION METHODS |
| WO2025077793A1 (zh) * | 2023-10-10 | 2025-04-17 | 康希诺生物股份公司 | 一种抗脑膜炎球菌的免疫组合物及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ545647A (en) * | 1999-05-19 | 2008-02-29 | Chiron Srl | Combination neisserial compositions |
| GB0103424D0 (en) * | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
| CU23236A1 (es) * | 2003-12-03 | 2007-09-26 | Ct Ingenieria Genetica Biotech | PROTEINA NMB0928 Y SU USO EN FORMULACIONES FARMACéUTICAS P |
-
2006
- 2006-03-31 CU CU20060075A patent/CU23575A1/es unknown
-
2007
- 2007-03-29 EP EP07721809A patent/EP2011509A2/en not_active Withdrawn
- 2007-03-29 BR BRPI0709922-3A patent/BRPI0709922A2/pt not_active IP Right Cessation
- 2007-03-29 WO PCT/CU2007/000013 patent/WO2007112703A2/es not_active Ceased
- 2007-03-29 CA CA002647465A patent/CA2647465A1/en not_active Abandoned
- 2007-03-29 US US12/295,198 patent/US20100129387A1/en not_active Abandoned
- 2007-03-29 AU AU2007234214A patent/AU2007234214A1/en not_active Abandoned
- 2007-03-29 MX MX2008012665A patent/MX2008012665A/es unknown
- 2007-03-29 KR KR1020087026335A patent/KR20080108576A/ko not_active Withdrawn
- 2007-03-29 CN CNA2007800182864A patent/CN101448518A/zh active Pending
- 2007-03-29 AR ARP070101323A patent/AR060797A1/es not_active Application Discontinuation
-
2008
- 2008-10-14 ZA ZA200808768A patent/ZA200808768B/xx unknown
- 2008-10-28 NO NO20084525A patent/NO20084525L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2647465A1 (en) | 2007-10-11 |
| BRPI0709922A2 (pt) | 2011-07-26 |
| WO2007112703A3 (es) | 2008-04-24 |
| WO2007112703A2 (es) | 2007-10-11 |
| ZA200808768B (en) | 2009-07-29 |
| CN101448518A (zh) | 2009-06-03 |
| AR060797A1 (es) | 2008-07-16 |
| NO20084525L (no) | 2008-11-28 |
| MX2008012665A (es) | 2008-10-13 |
| KR20080108576A (ko) | 2008-12-15 |
| EP2011509A2 (en) | 2009-01-07 |
| AU2007234214A1 (en) | 2007-10-11 |
| US20100129387A1 (en) | 2010-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McAuley et al. | Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease | |
| CY1123152T1 (el) | Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους | |
| BR112016003358A2 (pt) | método para aumentar a expressão de proteínas codificadas por rna | |
| BRPI0924460A2 (pt) | composição farmacêutica para uso em oftalmologia médica e veterinária | |
| CU23734A1 (es) | Polipéptidos inmunomoduladores derivados de la il-2 con actividad antagonista de esta citocina útiles en la terapia del cáncer y enfermedades infecciosas crónicas | |
| MX340541B (es) | Secuencias de aminoacidos mejoradas dirigidas contra virus sincitial respiratorio humano y polipeptidos que comprenden las mismas para la prevencion y/o tratamiento de infecciones del tracto respiratorio. | |
| PT2285408T (pt) | Sequências de aminoácidos dirigidas contra proteínas de envelope de um vírus e polipéptidos que as compreendem para o tratamento de doenças virais | |
| BRPI0416796A (pt) | compostos orgánicos | |
| MX377317B (es) | Compuestos de hormona de crecimiento humana recombinante unidos a peg. | |
| BR112012024379A2 (pt) | "peptídeos glucagon, seu uso, bem como composição farmacêutica" | |
| BR112014004860A2 (pt) | composições de anticorpo contra vírus da influenza | |
| WO2011110655A3 (en) | Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease | |
| WO2007022425A3 (en) | Influenza recombinant subunit vaccine | |
| BRPI0906710B8 (pt) | peptídeo derivado de pres modificado hidrofóbico de vírus da hepatite b (hbv) , peptídeo e composição farmacêutica | |
| ECSP12011959A (es) | SALES DE 4-[2-[[5-METIL-1-(2-NAFTALENIL)-1H-PIRAZOL-3-il]OXI]ETIL]MORFOLINA | |
| GEP201706766B (en) | Methods and compositions for vaccinating against staphylococcus aureus | |
| PH12013501373B1 (en) | Bovine viral diarrhea virus type 1b vaccine compositions and methods | |
| EA201690115A1 (ru) | Комбинированные иммуногенные композиции | |
| BR112014017141A2 (pt) | método de tratamento de diabetes usando-se apolipoproteína a-iv não glicosilada | |
| NZ712713A (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
| AR060796A1 (es) | Composicion farmaceutica que comprende la proteina nmb0938 | |
| AR060797A1 (es) | Composicion farmaceutica que comprende la proteina nmb0606 | |
| CU23584A1 (es) | Composición farmacéutica que comprende la proteína nmb1796 | |
| BR112015013625A2 (pt) | adjuvante de vacinação, preparação e vacinas contendo o mesmo | |
| CY1115322T1 (el) | Εκχυλισμα τριγωνελλας για τη θεραπεια νοσων στον ανθρωπο και τα ζωα στις οποιες εμπλεκονται μαστιγομορφα παρασιτα |